Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1998;109:27–38.

The discovery, development and clinical applications of granulocyte colony-stimulating factor.

D C Dale 1
PMCID: PMC2194342  PMID: 9601125

Abstract

The story of the discovery, development and applications of G-CSF illustrates many of the best features of modern laboratory and clinical investigation. The initial discovery of the CSFs was somewhat serendipitous. The pathway to understanding the cellular and molecular base for the action of these substances was long, but fruitful and exciting for those who pursued it tirelessly. The power of modern molecular biology is illustrated by the rapid advances which followed the cloning of the G-CSF gene. Major advances in our understanding of the regulation of neutrophil production and deployment have followed, together with many important clinical observations. To date hundreds of thousands of patients have been treated with G-CSF and some individuals with severe chronic neutropenia have received daily therapy for more than ten years. Results of recent studies suggest that there will be many more interesting and important clinical applications for G-CSF.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ATHENS J. W., HAAB O. P., RAAB S. O., MAUER A. M., ASHENBRUCKER H., CARTWRIGHT G. E., WINTROBE M. M. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest. 1961 Jun;40:989–995. doi: 10.1172/JCI104338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bensinger W. I., Price T. H., Dale D. C., Appelbaum F. R., Clift R., Lilleby K., Williams B., Storb R., Thomas E. D., Buckner C. D. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993 Apr 1;81(7):1883–1888. [PubMed] [Google Scholar]
  3. Bodey G. P., Buckley M., Sathe Y. S., Freireich E. J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966 Feb;64(2):328–340. doi: 10.7326/0003-4819-64-2-328. [DOI] [PubMed] [Google Scholar]
  4. Bradley T. R., Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci. 1966 Jun;44(3):287–299. doi: 10.1038/icb.1966.28. [DOI] [PubMed] [Google Scholar]
  5. Burgess A. W., Camakaris J., Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem. 1977 Mar 25;252(6):1998–2003. [PubMed] [Google Scholar]
  6. Burgess A. W., Metcalf D. Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells. Int J Cancer. 1980 Nov 15;26(5):647–654. doi: 10.1002/ijc.2910260517. [DOI] [PubMed] [Google Scholar]
  7. Chatta G. S., Price T. H., Allen R. C., Dale D. C. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers. Blood. 1994 Nov 1;84(9):2923–2929. [PubMed] [Google Scholar]
  8. Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991 Jul 18;325(3):164–170. doi: 10.1056/NEJM199107183250305. [DOI] [PubMed] [Google Scholar]
  9. Cutler R. L., Metcalf D., Nicola N. A., Johnson G. R. Purification of a multipotential colony-stimulating factor from pokeweed mitogen-stimulated mouse spleen cell conditioned medium. J Biol Chem. 1985 Jun 10;260(11):6579–6587. [PubMed] [Google Scholar]
  10. Daifuku R., Movahhed H., Fotheringham N., Bear M. B., Nelson S. Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia. Respir Med. 1996 Nov;90(10):587–592. doi: 10.1016/s0954-6111(96)90016-5. [DOI] [PubMed] [Google Scholar]
  11. Dale D. C., Bonilla M. A., Davis M. W., Nakanishi A. M., Hammond W. P., Kurtzberg J., Wang W., Jakubowski A., Winton E., Lalezari P. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood. 1993 May 15;81(10):2496–2502. [PMC free article] [PubMed] [Google Scholar]
  12. Dale D. C., Brown C. H., Carbone P., Wolff S. M. Cyclic urinary leukopoietic activity in gray collie dogs. Science. 1971 Jul 9;173(3992):152–153. doi: 10.1126/science.173.3992.152. [DOI] [PubMed] [Google Scholar]
  13. Dale D. C., Lau S., Nash R., Boone T., Osborne W. Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. J Infect Dis. 1992 Apr;165(4):689–694. doi: 10.1093/infdis/165.4.689. [DOI] [PubMed] [Google Scholar]
  14. Dale D. C., Liles W. C., Price T. H. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997 Sep;98(3):497–501. doi: 10.1046/j.1365-2141.1997.3023119.x. [DOI] [PubMed] [Google Scholar]
  15. Dale D. C., Liles W. C., Summer W. R., Nelson S. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases. J Infect Dis. 1995 Oct;172(4):1061–1075. doi: 10.1093/infdis/172.4.1061. [DOI] [PubMed] [Google Scholar]
  16. Dührsen U., Villeval J. L., Boyd J., Kannourakis G., Morstyn G., Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood. 1988 Dec;72(6):2074–2081. [PubMed] [Google Scholar]
  17. Foster R., Jr, Metcalf D., Robinson W. A., Bradley T. R. Bone marrow colony stimulating activity in human sera. Results of two independent surveys in Buffalo and Melbourne. Br J Haematol. 1968 Aug;15(2):147–159. doi: 10.1111/j.1365-2141.1968.tb01524.x. [DOI] [PubMed] [Google Scholar]
  18. Gabrilove J. L., Jakubowski A., Fain K., Grous J., Scher H., Sternberg C., Yagoda A., Clarkson B., Bonilla M. A., Oettgen H. F. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest. 1988 Oct;82(4):1454–1461. doi: 10.1172/JCI113751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gough A., Clapperton M., Rolando N., Foster A. V., Philpott-Howard J., Edmonds M. E. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet. 1997 Sep 20;350(9081):855–859. doi: 10.1016/S0140-6736(97)04495-4. [DOI] [PubMed] [Google Scholar]
  20. Hammond W. P., Csiba E., Canin A., Hockman H., Souza L. M., Layton J. E., Dale D. C. Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest. 1991 Feb;87(2):704–710. doi: 10.1172/JCI115049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ichikawa Y., Pluznik D. H., Sachs L. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A. 1966 Aug;56(2):488–495. doi: 10.1073/pnas.56.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Klebanoff S. J. Iodination of bacteria: a bactericidal mechanism. J Exp Med. 1967 Dec 1;126(6):1063–1078. doi: 10.1084/jem.126.6.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Larson R. S., Springer T. A. Structure and function of leukocyte integrins. Immunol Rev. 1990 Apr;114:181–217. doi: 10.1111/j.1600-065x.1990.tb00565.x. [DOI] [PubMed] [Google Scholar]
  24. Lieschke G. J., Grail D., Hodgson G., Metcalf D., Stanley E., Cheers C., Fowler K. J., Basu S., Zhan Y. F., Dunn A. R. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994 Sep 15;84(6):1737–1746. [PubMed] [Google Scholar]
  25. Liles W. C., Kiener P. A., Ledbetter J. A., Aruffo A., Klebanoff S. J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 1996 Aug 1;184(2):429–440. doi: 10.1084/jem.184.2.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Metcalf D., Begley C. G., Johnson G. R., Nicola N. A., Lopez A. F., Williamson D. J. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood. 1986 Jul;68(1):46–57. [PubMed] [Google Scholar]
  27. Metcalf D., Begley C. G., Williamson D. J., Nice E. C., De Lamarter J., Mermod J. J., Thatcher D., Schmidt A. Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol. 1987 Jan;15(1):1–9. [PubMed] [Google Scholar]
  28. Metcalf D., Stanley E. R. Quantitative studies on the stimulation of mouse bone marrow colony growth in vitro by normal human urine. Aust J Exp Biol Med Sci. 1969 Aug;47(4):453–466. doi: 10.1038/icb.1969.50. [DOI] [PubMed] [Google Scholar]
  29. Metcalf D. The colony stimulating factors. Discovery, development, and clinical applications. Cancer. 1990 May 15;65(10):2185–2195. doi: 10.1002/1097-0142(19900515)65:10<2185::aid-cncr2820651005>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  30. Metcalf D. The role of the colony-stimulating factors in resistance to acute infections. Immunol Cell Biol. 1987 Feb;65(Pt 1):35–43. doi: 10.1038/icb.1987.4. [DOI] [PubMed] [Google Scholar]
  31. Morstyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1988 Mar 26;1(8587):667–672. doi: 10.1016/s0140-6736(88)91475-4. [DOI] [PubMed] [Google Scholar]
  32. Pitrak D. L., Tsai H. C., Mullane K. M., Sutton S. H., Stevens P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest. 1996 Dec 15;98(12):2714–2719. doi: 10.1172/JCI119096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Price T. H., Chatta G. S., Dale D. C. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996 Jul 1;88(1):335–340. [PubMed] [Google Scholar]
  34. SBARRA A. J., KARNOVSKY M. L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959 Jun;234(6):1355–1362. [PubMed] [Google Scholar]
  35. Sachs L. The control of growth and differentiation in normal and leukemic blood cells. Cancer. 1990 May 15;65(10):2196–2206. doi: 10.1002/1097-0142(19900515)65:10<2196::aid-cncr2820651006>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  36. Sheridan W. P., Begley C. G., Juttner C. A., Szer J., To L. B., Maher D., McGrath K. M., Morstyn G., Fox R. M. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992 Mar 14;339(8794):640–644. doi: 10.1016/0140-6736(92)90795-5. [DOI] [PubMed] [Google Scholar]
  37. Sheridan W. P., Morstyn G., Wolf M., Dodds A., Lusk J., Maher D., Layton J. E., Green M. D., Souza L., Fox R. M. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet. 1989 Oct 14;2(8668):891–895. doi: 10.1016/s0140-6736(89)91552-3. [DOI] [PubMed] [Google Scholar]
  38. Stanley E. R., Hansen G., Woodcock J., Metcalf D. Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed Proc. 1975 Dec;34(13):2272–2278. [PubMed] [Google Scholar]
  39. Stanley E. R., Heard P. M. Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem. 1977 Jun 25;252(12):4305–4312. [PubMed] [Google Scholar]
  40. Tanaka H., Ishikawa K., Nishino M., Shimazu T., Yoshioka T. Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis. J Trauma. 1996 May;40(5):718–726. doi: 10.1097/00005373-199605000-00006. [DOI] [PubMed] [Google Scholar]
  41. Trillet-Lenoir V., Green J., Manegold C., Von Pawel J., Gatzemeier U., Lebeau B., Depierre A., Johnson P., Decoster G., Tomita D. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 1993;29A(3):319–324. doi: 10.1016/0959-8049(93)90376-q. [DOI] [PubMed] [Google Scholar]
  42. Waring P. M., Presneill J., Maher D. W., Layton J. E., Cebon J., Waring L. J., Metcalf D. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. Clin Exp Immunol. 1995 Dec;102(3):501–506. doi: 10.1111/j.1365-2249.1995.tb03844.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Weaver C. H., Hazelton B., Birch R., Palmer P., Allen C., Schwartzberg L., West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995 Nov 15;86(10):3961–3969. [PubMed] [Google Scholar]
  44. Welte K., Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996 Apr;72(4):158–165. doi: 10.1007/s002770050156. [DOI] [PubMed] [Google Scholar]
  45. Welte K., Gabrilove J., Bronchud M. H., Platzer E., Morstyn G. Filgrastim (r-metHuG-CSF): the first 10 years. Blood. 1996 Sep 15;88(6):1907–1929. [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES